Anna Emilia Kern
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anna Emilia Kern has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Anna S. Jankoschek
Medical University of Vienna, Vienna, Austria
2 shared publications- Benedikt Rumpf
Hospital Barmherzige Schwestern, Department of Surgery, Vienna, Austria
2 shared publications - Gregor Ortmayr
Center for Cancer Research, Medical University of Vienna, Vienna, Austria
2 shared publications Joel Probst
Department of Surgery, HPB Center, Vienna Health Network, Clinic Favoriten and Sigmund Freud Private University, Vienna, Austria
2 shared publications- Jonas Santol
Department of Surgery, HPB Center, Vienna Health Network, Clinic Favoriten and Sigmund Freud Private University, Vienna, Austria
2 shared publications Karl J. Oldhafer
Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Asklepios Hospital Barmbek, Hamburg, Germany; Semmelweis University Budapest, Asklepios Campus Hamburg, Hamburg, Germany
2 shared publications
Latest Publications
- Open Access
- 4 October 2024
- Published by Elsevier in JHEP Reports
- Vol. 7 (4) , 101226
Soluble TREM2 reflects liver fibrosis status and predicts postoperative liver dysfunction after liver surgery
- 4 October 2024
- Published by Elsevier in JHEP Reports
- Vol. 7 (4) , 101226
Open AccessSoluble TREM2 reflects liver fibrosis status and predicts postoperative liver dysfunction after liver surgery
- 3 September 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (11) , 108660
Impact of the future liver remnant volume before major hepatectomy
- 3 September 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (11) , 108660
Impact of the future liver remnant volume before major hepatectomy
- 3 October 2023
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 17 (10) , 959-973
The role of microRNAs in the different phases of liver regeneration
Since the first discovery of microRNAs (miRs) extensive evidence reveals their indispensable role in different patho-physiological processes. They are recognized as critical regulators of hepatic regeneration, as they modulate multiple complex signaling pathways affecting liver regeneration. MiR-related translational suppression and degradation of target mRNAs and proteins are not limited to one specific gene, but act on multiple targets. In this review, we are going to explore the role of miRs in the context of liver regeneration and discuss the regulatory effects attributed to specific miRs. Moreover, specific pathways crucial for liver regeneration will be discussed, with a particular emphasis on the involvement of miRs within the respective signaling cascades. The considerable amount of studies exploring miR functions in a variety of diseases paved the way for the development of miR-directed therapeutics. Clinical implementation has already shown promising results, but additional research is warranted to assure safe and efficient delivery. Nevertheless, given the broad functional properties of miRs and their critical involvement during hepatic regeneration, they represent an attractive treatment target to promote liver recovery after hepatic resection.
- 3 October 2023
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 17 (10) , 959-973
The role of microRNAs in the different phases of liver regeneration
Since the first discovery of microRNAs (miRs) extensive evidence reveals their indispensable role in different patho-physiological processes. They are recognized as critical regulators of hepatic regeneration, as they modulate multiple complex signaling pathways affecting liver regeneration. MiR-related translational suppression and degradation of target mRNAs and proteins are not limited to one specific gene, but act on multiple targets. In this review, we are going to explore the role of miRs in the context of liver regeneration and discuss the regulatory effects attributed to specific miRs. Moreover, specific pathways crucial for liver regeneration will be discussed, with a particular emphasis on the involvement of miRs within the respective signaling cascades. The considerable amount of studies exploring miR functions in a variety of diseases paved the way for the development of miR-directed therapeutics. Clinical implementation has already shown promising results, but additional research is warranted to assure safe and efficient delivery. Nevertheless, given the broad functional properties of miRs and their critical involvement during hepatic regeneration, they represent an attractive treatment target to promote liver recovery after hepatic resection.